Mozarin (Escitalopram)

Escitalopram selectively blocks the serotonin transporter, preventing reuptake of serotonin into presynaptic neurons. This raises serotonin levels in the synaptic cleft, enhancing serotonergic signaling, which contributes to mood stabilization and anxiety reduction.

The specific dose of Mozarin is determined by the prescribing clinician based on the individual’s condition, severity, and response to therapy. Dosage adjustments are made according to clinical guidelines and patient tolerance.

Safety of escitalopram in pregnancy or lactation has not been definitively established. Clinicians should weigh potential benefits against risks and consider alternative treatments when appropriate. Pregnant or nursing patients should discuss options with their healthcare provider.

To order Mozarin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other SSRIs, escitalopram (Mozarin) is often noted for its high selectivity for the serotonin transporter and a favorable side‑effect profile. It may be preferred when patients experience intolerable side effects with less selective agents, though individual response varies.

Mozarin should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme heat to maintain stability and potency.

Mozarin is taken orally, usually once daily with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or split unless instructed.

Serious risks include the potential for serotonin syndrome, emergence of suicidal thoughts or behaviors, severe allergic reactions, QT interval prolongation, and abnormal bleeding. Patients should seek immediate medical attention if they experience any of these symptoms.

Mozarin is contraindicated in patients with known hypersensitivity to escitalopram or any SSRI components, those currently taking MAO inhibitors, and individuals with a history of severe QT prolongation or ventricular arrhythmias. Clinicians should also avoid use in patients with uncontrolled narrow‑angle glaucoma.